The historical rank and industry rank for Kindstar Globalgene Technology's EV-to-FCF or its related term are showing as below:
KDGTF'
s EV-to-FCF Range Over the Past 10 Years
Min: -1.89 Med: 5.34 Max: 129.66
Current: 2.04
During the past 6 years, the highest EV-to-FCF of Kindstar Globalgene Technology was 129.66. The lowest was -1.89. And the median was 5.34.
KDGTF's EV-to-FCF is ranked better than 92.13% of 89
companies
in the Medical Diagnostics & Research industry
Industry Median: 25.17
vs KDGTF: 2.04
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kindstar Globalgene Technology's EV-to-FCF
For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kindstar Globalgene Technology's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Kindstar Globalgene Technology's EV-to-FCF falls into.
Kindstar Globalgene Technology's current Enterprise Value is $241.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kindstar Globalgene Technology's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-26.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Kindstar Globalgene Technology's PE Ratio for today is calculated as:
Kindstar Globalgene Technology's share price for today is $0.6833.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kindstar Globalgene Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Kindstar Globalgene Technology EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Kindstar Globalgene Technology's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Kindstar Globalgene Technology (Kindstar Globalgene Technology) Business Description
Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services. It organizes the business into nine segments, including hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, and Other segment provides Testing services for R&D projects and others and miscellaneous services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KDGTF has been successfully added to your 